SEARCH

SEARCH BY CITATION

References

  • Balch, C.M., Gershenwald, J.E., Soong, S.J. et al. (2009). Final version of 2009 AJCC melanoma staging and classification. J. Clin. Oncol. 27, 61996206.
  • Baumann, U., Huber, R., Bode, W., Grosse, D., Lesjak, M., and Laurell, C.B. (1991). Crystal structure of cleaved human alpha 1-antichymotrypsin at 2.7 A resolution and its comparison with other serpins. J. Mol. Biol. 218, 595606.
  • Bosserhoff, A.K. (2005). Melanoma inhibitory activity (MIA): an important molecule in melanoma development and progression. Pigment Cell Res. 18, 411416.
  • Gould Rothberg, B.E., Bracken, M.B., and Rimm, D.L. (2009). Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis. J. Natl. Cancer Inst. 101, 452474.
  • Homsi, J., Kashani-Sabet, M., Messina, J.L., and Daud, A. (2005). Cutaneous melanoma: prognostic factors. Cancer Control 12, 223229.
  • Kondo, Y., and Ohsawa, N. (1982). Production of human alpha 1-antichymotrypsin-like protein by a human malignant melanoma transplanted into nude mice. Cancer Res. 42, 15491554.
  • Naidoo, N., Cooperman, B.S., Wang, Z.M., Liu, X.Z., and Rubin, H. (1995). Identification of lysines within alpha 1-antichymotrypsin important for DNA binding. An unusual combination of DNA-binding elements. J. Biol. Chem. 270, 1454814555.
  • Nikkola, J., Vihinen, P., Vlaykova, T., Hahka-Kemppinen, M., Heino, J., and Pyrhonen, S. (2004). Integrin chains beta1 and alphav as prognostic factors in human metastatic melanoma. Melanoma Res. 14, 2937.
  • Nikkola, J., Vihinen, P., Vuoristo, M.S., Kellokumpu-Lehtinen, P., Kahari, V.M., and Pyrhonen, S. (2005). High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma. Clin. Cancer Res. 11, 51585166.
  • Tang, L., Dai, D.L., Su, M., Martinka, M., Li, G., and Zhou, Y. (2006). Aberrant expression of collagen triple helix repeat containing 1 in human solid cancers. Clin. Cancer Res. 12, 37163722.
  • Tarhini, A.A., Stuckert, J., Lee, S., Sander, C., and Kirkwood, J.M. (2009). Prognostic significance of serum S100B protein in high-risk surgically resected melanoma patients participating in Intergroup Trial ECOG 1694. J. Clin. Oncol. 27, 3844.
  • Zhou, Y., Dai, D.L., Martinka, M. et al. (2005). Osteopontin expression correlates with melanoma invasion. J. Invest. Dermatol. 124, 10441052.